Allscripts, Humana partner to provide clinical-decision support technology for physicians Humana Inc. , in its continuing commitment to partnering with leading Electronic Wellness Record vendors, has created an alliance with Allscripts – a national head in EHR technology – to supply eligible physician practices with incentives for implementing EHR technology that enables delivery of advanced clinical-decision support at the point of care. The technology provides patient-specific, clinical-quality info to doctors that supports both preventive and chronic-condition management and also improved treatment coordination drugs information . Humana will provide financial assist with selected physicians for adoption of the Allscripts EHR within Humana’s Medical Home EHR Rewards Program.
For aclidinium to Forest Laboratories, Inc., Forest and Almirall will co-promote aclidinium in Canada. Almirall maintains rights for all of those other world.. Almirall, Forest Laboratories’ Tudorza Pressair now available in the U.S. Pharmacies Forest Laboratories, Inc. and Almirall, S.A. Tudorza is usually a long-acting anticholinergic lately authorized by the U.S. Food and Medication Administration for the long-term, maintenance treatment of bronchospasm connected with chronic obstructive pulmonary disease , including persistent bronchitis and emphysema. Tudorza is the initial long-acting inhaled anticholinergic accepted by the FDA in over 8 years for COPD and can be administered twice daily through the preloaded, multidose Pressair inhaler. Almirall granted commercialization privileges in the U.S.